Skip to content

Advertisement

Open Access

Specific inhibition of adenylyl-cyclase isoform 5 by mood stabilizers may be related to their mechanism of action

  • Liad Mann1,
  • Eliahu Heldman1,
  • Yuly Bersudsky1,
  • Orna Almog1,
  • RH Belmaker1 and
  • Galila Agam1
Annals of General Psychiatry20109(Suppl 1):S83

https://doi.org/10.1186/1744-859X-9-S1-S83

Published: 22 April 2010

Keywords

LithiumCarbamazepineValproateCOS7 CellMood Stabilizer

Lithium, valproate and carbamazepine decrease brain cAMP. Adenylyl-cyclase (AC), which synthesizes cAMP has nine membrane-bound isoforms (AC1-AC9). In this study we used COS7 cells transfected with cDNA of each of the isoforms to study the effect of a therapeutic concentration of each of lithium, carbamazepine and valproate on ACs activity. AC5 was the most inhibitable isoform by lithium and carbamazepine either when stimulated by forskolin or by a D1 agonist. Ten mM Mg2+ reduced lithium-induced AC5 inhibition by 70% and in silico analysis suggested that carbamazepine preferentially affects AC1 and AC5 by interacting with two amino-acids at the catechol-estrogen binding site region. Valproate did not inhibit any AC isoform suggesting it decreases cAMP levels via a different mechanism. AC5 knockout mice behaved in the forced-swim-test similarly to antidepressant- or lithium-treated wildtypes implying that AC5 inhibition may be involved in the antidepressant effect of lithium and carbamazepine. Specific AC5 inhibitors may be mood-stabilizers or antidepressants.

Authors’ Affiliations

(1)
Psychiatry Research Unit and Department of Clinical Biochemistry, Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer-Sheva, Israel

Copyright

© Mann et al.; licensee BioMed Central Ltd. 2009

This article is published under license to BioMed Central Ltd.

Advertisement